Long-term lithium treatment increases intracellular and extracellular brain-derived neurotrophic factor (BDNF) in cortical and hippocampal neurons at subtherapeutic concentrations

Bipolar Disorders

Volumn 18, Issue 8, 2016, Pages 692-695

  De Paula, Vanessa J ^a   Gattaz, Wagner F ^a   Forlenza, Orestes V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

BDNF; chronic lithium treatment; cortical neurons; hippocampal neurons; low dose lithium treatment

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LITHIUM CHLORIDE; LITHIUM; NEUROPROTECTIVE AGENT; TRANQUILIZER;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; EMBRYO; EXTRACELLULAR SPACE; HIPPOCAMPAL NEURONAL CULTURE; LONG TERM EXPOSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; UPREGULATION; ADVERSE DRUG REACTION; ANIMAL; BIPOLAR DISORDER; CELL CULTURE; CHEMICALLY INDUCED; DEPRESSIVE DISORDER, MAJOR; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; METABOLISM; NERVE CELL;

ANIMALS; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CEREBRAL CORTEX; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; LITHIUM; LONG TERM ADVERSE EFFECTS; NEURONS; NEUROPROTECTIVE AGENTS; RATS;

EID: 85008430109     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12449     Document Type: Article

References (30)

1. Jiao Y, Palmgren B, Novozhilova E, et al. BDNF increases survival and neuronal differentiation of human neural precursor cells cotransplanted with a nanofiber gel to the auditory nerve in a rat model of neuronal damage. Biomed Res Int 2014; 2014:356415.
2. Machado-Vieira R, Manji HK, Zarate CA Jr. The role of lithium in the treatment of bipolar disorder: Convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 2009;11(Suppl. 2):92–109.
3. Smith ED, Prieto GA, Tong L, et al. Rapamycin and interleukin-1β impair brain-derived neurotrophic factor-dependent neuron survival by modulating autophagy. J Biol Chem. 2014;289:20615–20629.
4. Huang EJ, Reichardt LF. Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci. 2001; 24:677–736. Review.
5. Mariga A, Mitre M, Chao MV. Consequences of Brain-Derived Neurotrophic Factor withdrawal in CNS neurons and implications in disease. Neurobiol Dis. 2016;61:353–355.
6. McAllister AK. Subplate neurons: A missing link among neurotrophins, activity, and ocular dominance plasticity? Proc Natl Acad Sci USA. 1999;96:1360–1362.
7. Forlenza OV, De-Paula VJ, Diniz BS, Neuroprotective effects of lithium: Implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. ACS Chem Neurosci. 2014;5:443–450. Review.
8. Gromova OA, Torshin LY, Gogoleva IV, et al. Pharmacokinetic and pharmacodynamic synergism between neuropeptides and lithium in the neurotrophic and neuroprotective action of cerebrolysin. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115:65–72.
9. Nunes MA, Schöwe NM, Monteiro-Silva KC, et al. Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease. PLoS ONE. 2015;25:e0142267.
10. 2, activity in cultured cortical and hippocampal neurons. Molecules. 2015;20:19878–19885.
11. Vo TM, Perry P, Ellerby M, Bohnert K. Is lithium a neuroprotective agent? Ann Clin Psychiatry. 2015; 1:49–54. Review.
12. De-Paula VJ, Kerr DS, Scola G, Gattaz WF, Forlenza OV. Lithium distinctly modulates the secretion of pro and anti-inflammatory interleukins in co-cultures of neurons and glial cells at therapeutic and sub-therapeutic concentrations. Curr Alzheimer Res. 2016;2016(13):848–852.
13. Toker L, Agam G. Lithium, inositol and mitochondria. ACS Chem Neurosci. 2014;6:411–412.
14. Motoi Y, Shimada K, Ishiguro K, Hattori N. Lithium and autophagy. ACS Chem Neurosci. 2014;5:434–442.
15. Lovestone S, Davis DR, Webster MT, et al. Lithium reduces tau phosphorylation: Effects in living cells and in neurons at therapeutic concentrations. Biol Psychiatry. 1999;45:995–1003.
16. Damri O, Sade Y, Toker L, et al. Molecular effects of lithium are partially mimicked by inositol-monophosphatase (IMPA)1 knockout mice in a brain region-dependent manner. Eur Neuropsychopharmacol. 2015;25:425–434.
17. Bachmann RF, Schloesser RJ, Gould TD, Manji HK. Mood stabilizers target cellular plasticity and resilience cascades: Implications for the development of novel therapeutics. Mol Neurobiol 2005; 32:173–202. Review.
18. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology. 2001;158:100–106.
19. Hashimoto R, Takei N, Shimazu K, Christ L, Lu B, Chuang DM. Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: An essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology. 2002;43:1173–1179.
20. Schwieger J, Warnecke A, Lenarz T, Esser KH, Scheper V. Neuronal Survival, Morphology and Outgrowth of Spiral Ganglion Neurons Using a Defined Growth Factor Combination. PLoS ONE. 2015;10:e0133680.
21. Dwivedi T, Zhang H. Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteins. Front Neurosci. 2015;8:457.
22. Emamghoreishi M, Keshavarz M, Nekooeian AA. Acute and chronic effects of lithium on BDNF and GDNF mRNA and protein levels in rat primary neuronal, astroglial and neuroastroglia cultures. Iran J Basic Med Sci. 2015;18:240–246.
23. Park SW, Lee JG, Seo MK, et al. Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons. Bipolar Disord. 2015;17:278–290.
24. Su H, Zhang W, Guo J, Guo A, Yuan Q, Wu W. Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor. J Neurochem. 2009;108:1385–1398.
25. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S. Distribution of BDNF protein and mRNA in the normal adult rat CNS: Evidence for anterograde axonal transport. J Neurosci. 1997;17:2295–2313.
26. Solntseva EI, Bukanova JV, Kondratenko RV, Skrebitsky VG. Lithium ions in nanomolar concentration modulate glycine-activated chloride current in rat hippocampal neurons. Neurochem Int. 2016;94:67–73.
27. Guttuso T Jr. Low-dose lithium adjunct therapy associated with reduced off-time in Parkinson's disease: A case series. J Neurolog Sci. 2016;368:221–222.
28. Kaplan GB, Vasterling JJ, Vedak PC. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: Role in pathogenesis and treatment. Behav Pharmacol. 2010;21:427–437.
29. Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: Randomised controlled trial. Br J Psychiatry. 2011;198:351–356.
30. Sarkar S, Floto RA, Berger Z, et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol. 2005;170:1101–1111.